Bristol Myers Squibb Deepens Commitment to Healthcare Professionals Through Champions in Care Movement 01 October
U.S. Food and Drug Administration Approves Expanded Indication for Bristol Myers Squibb's CAMZYOS® for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy in Adults and Pediatric Patients* 30 September
Care Within Reach: How the Bristol Myers Squibb Foundation Is Strengthening Health Systems Across Africa 28 September
